Theyre reading primary research, comparing outcomes, and discovering a MASSIVE gap between what conventional medicine offers and whats actually available
Complete resolution 6-8 weeks typical
Epithalon is not approved for human use in non-research settings
[10] [18] [19] Enhancement of dopaminergic neurotransmission is observed in the hypothalamus, striatum, ventral tegmental area, nucleus accumbens, and other regions
Store lyophilized vials at -20C for long-term stability
When side effects do occur, they're typically mild: Common (mild): Drowsiness or fatigue (especially initially) Slight warmth or flushing Vivid dreams or altered sleep patterns Injection site reactions (redness, slight swelling) Rare: Headaches Mood changes Appetite fluctuations Important note : Serious adverse effects are extremely rare in the literature and user reports when proper epithalon peptide dosage guidelines are followed